More conditions included in the New Medicines Service
More conditions included in the New Medicine Service
Thirteen conditions were added to the New Medicine Service (NMS) in the CPCF from September 2021 in a move that was broadly welcomed across the sector:
- Acute coronary syndrome (ACS)
- Atrial fibrillation (AF)
- Coronary heart disease
- Epilepsy
- Glaucoma
- Gout
- Heart failure
- Hypercholesterolaemia
- Long-term risks of venous thromboembolism/embolism
- Osteoporosis
- Parkinson’s disease
- Stroke/transient ischaemic attack
- Urinary incontinence and retention.
The directions for the NMS now permit contractors who have received an exemption from the requirement to have a consultation room (due to their premises size) to provide the service remotely or at a patient’s home. All other contractors providing the service can similarly continue to provide the service remotely, where appropriate, and in the patient’s home.